Projects In Knowledge

The Advanced Certificate Program in Breast Cancer Management III

Projects In Knowledge is pleased to present The Advanced Certificate Program: Breast Cancer Management comprised of Curricula I and II.
Curriculum I courses present a basic overview of management strategies for optimal personalized care of breast cancer patients. Curriculum II presents more advanced courses that build on new scientific developments and the topics covered in Curriculum I. Curriculum III presented by Albert Einstein College of Medicine and Projects In Knowledge provides updates on prognostic tools, newer targeted treatments, and safety of hormonal therapies and chemotherapy. It also includes case studies illustrating management decisions and treatment options for patients with refractory HER2-positive or hormone-receptor–positive metastatic breast cancer.
Featuring the very latest state-of-the-science information about breast cancer diagnosis, breast cancer treatment, and breast cancer disease management, this free online curriculum offers CME, CE, and CPE credit to oncologists and other clinicians who care for patients with breast cancer.
The curriculum courses are updated continuously throughout the year. The Advanced Certificate Program: Breast Cancer Management is building a community of experts to help you provide your patients with the best treatment outcome possible....more

H. Burstein, MD, PhD

The Advanced Certificate Program in Lung Cancer Management III

This free yearlong CME/CE program provides clinicians with up-to-date information about the management of lung cancer, featuring an expert faculty co-chaired by Roy S. Herbst, MD, PhD, and Corey J. Langer, MD, FACP, and a comprehensive curriculum of 24 web-based courses. Get timely and practical information that you can immediately use in caring for your patients with lung cancer....more

R. Herbst, MD, PhD

C. Langer, MD, FACP

The Certificate Program in Advanced/Metastatic Colorectal Cancer

Featuring the most up-to-date information available about diagnostic methods used to screen for advanced/metastatic colorectal cancer, practice guidelines, and current and emerging treatment strategies....more

L. Saltz, MD

The Advanced Certificate Program: Breast Cancer Management II.

Projects In Knowledge is pleased to present The Advanced Certificate Program: Breast Cancer Management comprised of Curricula I and II.

Curriculum I courses present a basic overview of management strategies for optimal personalized care of breast cancer patients.
Curriculum II presents more advanced courses that build on new scientific developments and the topics covered in Curriculum I.

Featuring the very latest state-of-the-science information about breast cancer diagnosis, breast cancer treatment, and breast cancer disease management, this free online curriculum offers CME, CE, and CPE credit to oncologists and other clinicians who care for patients with breast cancer.

The curriculum courses are updated continuously throughout the year.

The Advanced Certificate Program: Breast Cancer Management is building a community of experts to help you provide your patients with the best treatment outcome possible....more

H. Burstein, MD, PhD

The Advanced Certificate Program in Hepatocellular Carcinoma Management

Projects In Knowledge is pleased to present The Advanced Certificate Program in Hepatocellular Carcinoma. This program offers CME and CE credit to oncologists, gastroenterologists, hepatologists, radiologists, surgeons, and other clinicians involved in the care of patients with hepatocellular carcinoma....more

G. Davis, MD

J. Geschwind, MD

The Advanced Certificate Program in Lung Cancer Management II

R. Herbst, MD, PhD

C. Langer, MD, FACP

The Advanced Certificate Program in Caring for Oncology Patients: Tips and Tools for Managing Targeted Therapy

This free and convenient online CME/CE program, co-chaired by Theresa W. Gillespie, BA, BSN, MA, PhD, RN, and Hai T. Tran, PharmD, promises to be a timely and continuously updated source of practical information that oncologists, nurses, and pharmacists can immediately use in treating, monitoring, and managing side effects in cancer patients receiving targeted therapy. Enroll today!...more

T. Gillespie, BA, BSN, MA, PhD, RN

H. Tran, PharmD

The Advanced Certificate Program in Breast Cancer Management

Projects In Knowledge is pleased to present The Advanced Certificate Program: Breast Cancer Management.

Featuring the very latest state-of-the-science information about breast cancer diagnosis, breast cancer treatment, and breast cancer disease management, this free online curriculum offers CME, CE, and CPE credit to oncologists and other clinicians who care for patients with breast cancer.

The curriculum courses are updated continuously throughout the year.

The Advanced Certificate Program: Breast Cancer Management is building a community of experts to help you provide your patients with the best treatment outcome possible....more

H. Burstein, MD, PhD

The Advanced Certificate Program in Lung Cancer Management

Enroll today in this free yearlong CME/CE program, which provides clinicians with up-to-date information about the management of lung cancer. This outstanding program features an expert faculty co-chaired by Roy S. Herbst, MD, PhD, and Corey J. Langer, MD, FACP, and a comprehensive curriculum of 24 web-based courses. Get timely and practical information that you can immediately use in caring for your patients with lung cancer....more

R. Herbst, MD, PhD

C. Langer, MD, FACP

Women's Cancers Edition

More than 250,000 women will be diagnosed with breast, ovarian, cervical, or endometrial/uterine cancer this year. In each of the six chapters, an oncology expert will focus on one cancer type or stage, elucidating the current standard of care, as well as highlighting what's on the horizon with therapies in development.

Please join the expert faculty for each chapter of this online and interactive "living" textbook....more

R. Coleman, MD

M. Fornier, MD

T. Herzog, MD

B. Monk, MD, FACOG, FACS

R. Morris, MD

P. Morris, MD, MSc, MRCPI

Tumor Immunology and Immunotherapy: Metastatic Melanoma Edition

This "living" textbook is an interactive and up-to-date resource to support learning in the field of tumor immunology, and more specifically focuses on melanoma treatment and management. Chapter 1 provides a broad review of all of the cells in the innate and adaptive immune systems and briefly introduces concepts relating to the immune system's role in detecting and eliminating tumor cells. ...more

J. Weber, MD, PhD

Lung Cancer — Zeroing in on Non-Small Cell Lung Cancer: Integrating Targeted Therapies into Practice

In this free CME/CE on-demand webcast, a panel of experts in the use of targeted therapies to treat patients with NSCLC will provide up-to-date information on optimizing the use of targeted agents, discussing genomic predictors and their application in determining therapy with targeted agents, current and emerging targeted therapies, and multimodality radiotherapy/targeted therapy. ...more

W. Curran, Jr., MD

Colorectal Cancer — The Art of Individualized Treatment in the Management of Colorectal Cancer

Managing a patient with colorectal cancer is increasingly a matter of individualized treatment, and it requires that the clinician have current knowledge not only of therapies, but also the underlying molecular biology. This complex topic is summarized in an on-demand, interactive webcast with a case study, presented by three noted clinical oncologists. Jeffrey A. Meyerhardt, MD, MPH, of Harvard Medical School/Dana-Farber Cancer Institute, Alan Venook, MD, of UCSF, and Richard M. Goldberg, MD, of the University of North Carolina, review and summarize the pertinent scientific and therapeutic data. Throughout, you have the opportunity to add your own input on appropriate management and compare your answers with those of your colleagues....more

R. Goldberg, MD

Breast Cancer — From Science to Practice:Managing CINV and Pain in Breast Cancer

Examine the prevalence of chemotherapy-induced nausea and vomiting (CINV) and pain in breast cancer patients, the impact of these events on refusal/delay of treatment, and specific problems in managing acute, delayed and breakthrough CINV. Discussion includes management with current and novel products, including neuromodulation/cannibinoids....more

Breast Cancer — Expert Insight Into: The Combination of Two Anti-HER2 Monoclonal Antibodies in Patients with HER2-Positive Metastatic Breast Cancer that Progressed During Prior Therapy with One of These Agents. (Part 5 of Series)

Francisco J. Esteva, MD, PhD, reports on the encouraging results of a phase II trial of the combination of trastuzumab plus pertuzumab for the treatment of breast cancer that progressed on trastuzumab treatment. His discussion places these data in the context of preliminary results of other emerging second-line trastuzumab-containing combinations....more

F. Esteva, MD, PhD

Breast Cancer — Expert Insight Into: Initial Assessment, Surveillance, and Management of Blood Pressure in Patients Receiving VEGF Inhibitors. (Part 4 of Series)

Harold J. Burstein, MD, PhD, reports on the results of a recently published study that focused on blood pressure assessment and management in patients who take vascular endothelial growth factor (VEGF) inhibitors. Dr. Burstein’s synopsis succinctly captures the key points of this study, which presents a set of principles to guide safer use of VEGF inhibitors by individual clinicians who treat patients with cancer....more

H. Burstein, MD, PhD

Breast Cancer — Expert Insight Into: Aspirin Intake and Survival After Breast Cancer (Part 3 of Series)

Lisa A. Carey, MD, ScM, reviews the recently published Aspirin Intake and Survival After Breast Cancer study, a prospective observational subgroup study of women from the Nurse’s Health Study who used aspirin after they were diagnosed with breast cancer. The results of this study are provocative but warrant further research to confirm their validity....more

L. Carey, MD, ScM

Lung Cancer — Expert Insight Into: Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung Cancer (Part 7 of Series)

Corey J. Langer, MD, FACP, discusses results from a recent phase 2 study of stereotactic body radiation therapy for the treatment of early-stage NSCLC patients with medically inoperable peripheral tumors. The study reported encouraging results regarding overall survival rates, local tumor control, and treatment-related morbidity compared with those seen with radiation therapy and observation without specific cancer therapy, which are the conventional treatment options for these patients....more

C. Langer, MD, FACP

Breast Cancer — Case Study: Refractory HER2-Positive Metastatic Breast Cancer

Francisco J. Esteva, MD, PhD, considers first-, second-, and third-line treatment options for a 54-year-old case patient with HER2-positive, hormone-responsive metastatic breast cancer. Dr. Esteva also provides expert guidance on how to choose between combinations of HER2-targeting therapies, endocrine therapies, and chemotherapies....more

H. Burstein, MD, PhD

Lung Cancer — Expert Insight Into: EGFR Tyrosine Kinase Inhibitor as Maintenance Therapy for Advanced NSCLC (Part 6 of Series)

Roy S. Herbst, MD, PhD, discusses a recent study that compared maintenance therapy with the EGFR tyrosine kinase inhibitor erlotinib versus placebo. The findings add to the mounting evidence that administering maintenance therapy prior to disease progression may improve progression-free survival in patients with advanced or metastatic NSCLC....more

R. Herbst, MD, PhD

Breast Cancer — Expert Insight Into: Recurrence Score for Distant Recurrence Risk in Node-Negative/Node-Positive Postmenopausal Breast Cancer Patients Receiving Hormone Therapy (Part 2 of Series)

Dr. Harold Burstein reviews and discusses a new study showing that the Recurrence Score, based on breast cancer gene expression, has independent power for predicting distant recurrence risk in postmenopausal patients with estrogen receptor-positive breast cancer and node-negative or node-positive status who are receiving hormone therapy...more

H. Burstein, MD, PhD

Breast Cancer — Expert Insight Into: Prevention of Aromatase Inhibitor-Induced Bone Loss Using a Bisphosphonate: The SABRE Trial (Part 1 of Series)

Join Dr. Harold J. Burstein as he describes the findings from the SABRE trial, which assessed the effects of a bisphosphonate in preserving bone mineral density in postmenopausal women at moderate and high risk of fragility fracture who were receiving an aromatase inhibitor for the treatment of early breast cancer....more

H. Burstein, MD, PhD

Breast Cancer — The Advanced Certificate Program in Breast Cancer Management III

H. Burstein, MD, PhD

Lung Cancer — Case Study: EGFR Mutation Testing in a Never-Smoker with Advanced Stage NSCLC

Dr. Corey Langer presents the case of a 74-year-old woman with a right upper lobe nodule and pleural effusion, describing how to choose diagnostic tests that will facilitate both traditional pathologic evaluation and molecular testing. With an emphasis on individualizing the workup and management of patients with advanced NSCLC, Dr. Langer also evaluates treatment options, taking into account EGFR mutation status....more

C. Langer, MD, FACP